Cost Effectiveness of Zanamivir for the Treatment of Influenza in a High Risk Population in Australia

ISSN： 1170-7690

Source： PharmacoEconomics, Vol.17, Iss.6, 2000-06, pp. : 611-620

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients

By Griffin A.D.

PharmacoEconomics, Vol. 19, Iss. 3, 2001-03 ,pp. : 293-301

Adis International

Access to resources Recommend Favorite

Zanamivir in the treatment of influenza

By Fleming Douglas M

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 5, 2003-05 ,pp. : 799-805

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Oseltamivir Treatment for Patients with Influenza-Like Illness Who Are at Increased Risk for Serious Complications of Influenza: Illustration for The Netherlands

By Postma Maarten J.

PharmacoEconomics, Vol. 25, Iss. 6, 2007-01 ,pp. : 497-509

Adis International

Access to resources Recommend Favorite

Debating the cost effectiveness of zanamivir vs oseltamivir

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 319, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Household Transmission of Influenza (H1N1-2009) in Japan: Age-specificity and Reduction of Household Transmission Risk by Zanamivir Treatment

By Nishiura H Oshitani H

The Journal of International Medical Research, Vol. 39, Iss. 2, 2011-03 ,pp. : 619-628

Field House Publishing

Access to resources Recommend Favorite